A Resolution recognizing April 25, 2026, as "Diabetic Eye Screening Day" in Pennsylvania.
Take action
Record your position on this measure.
Create an account to take a stance, submit a written position, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Overview
This resolution designates April 25, 2026, as "Diabetic Eye Screening Day" in Pennsylvania. It recognizes the importance of early detection and treatment for diabetic retinopathy, a leading cause of blindness among people with diabetes. The resolution highlights efforts by various organizations, including hospitals and optometry schools, to provide free or low-cost eye screenings to raise awareness about the need for regular diabetic eye evaluations.
Key provisions
- Designates April 25, 2026, as "Diabetic Eye Screening Day" in Pennsylvania.
- Recognizes diabetic retinopathy as a leading cause of blindness in people with diabetes.
- Highlights the importance of early detection and treatment for diabetic retinopathy.
- Lists participating organizations offering free or low-cost screenings.
- Acknowledges efforts in surrounding states (Delaware and Maryland) to promote diabetic eye screenings.
Who is affected
- People with diabetes
- Ophthalmologists
- Optometrists
- Patients in Pennsylvania
- Residents of Delaware and Maryland
Notable changes
- None explicitly stated in the text; it primarily focuses on recognition and awareness.
Bill text
Read the latest version inline or switch to a previous version.
Document of record
- Version
- Pn 2978 Html
- Published
- Not published in the source record
This version is published only as a document. Open the viewer to read it here, or download the file.
Sponsors
Official sponsors from legislative records.
9 on record
Primary sponsor
Cosponsors
Benjamin Sanchez
MaryLouise Isaacson
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours